Immunosuppressant-Driven De Novo Malignant Neoplasms after Solid-Organ Transplant

Targeting PI3K/Akt/mTOR Signaling in Cancer

(2014) Camillo Porta et al.   Frontiers in Oncology

ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education--2012

(2013) C. A. Pedersen et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

The impact of calcineurin inhibitors on graft survival

(2013) David Rush   Transplantation Reviews

New concepts and best practices for management of pre- and post-transplantation cancer

(2012) Josep M. Campistol et al.   Transplantation Reviews

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

(2011) Eric A. Engels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence and Risk Factors for Nonmelanoma Skin Cancer After Heart Transplantation

(2010) B.D. Molina et al.   TRANSPLANTATION PROCEEDINGS

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

(2009)   AMERICAN JOURNAL OF TRANSPLANTATION

Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review

(2009) Simon R. Knight et al.   TRANSPLANTATION

Maintenance Immunosuppression With Mycophenolate Mofetil: Long-Term Efficacy and Safety After Heart Transplantation

(2009) M. Dandel et al.   TRANSPLANTATION PROCEEDINGS

Molecular and Immunologic Mechanisms of Cancer Pathogenesis in Solid Organ Transplant Recipients

(2008) O. M. Martinez et al.   AMERICAN JOURNAL OF TRANSPLANTATION